Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CLN3, the protein associated with batten disease: structure, function and localization.

Seasson N Phillips1, Jared W Benedict, Jill M Weimer

  • 1Center for Aging and Developmental Biology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.

Journal of Neuroscience Research
|January 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic uncertainty as a public health imperative: a call for R69 code adoption.

Diagnosis (Berlin, Germany)·2026
Same author

Longitudinal deep multi-omics profiling in a CLN3<sup>Δex7/8</sup> minipig model identifies biomarker signatures of disease.

Communications medicine·2026
Same author

Diversity of DNA viruses in the atmosphere of sub-Antarctic South Georgia.

Frontiers in microbiology·2026
Same author

High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lymphoid Cells in autoimmune disease risk.

bioRxiv : the preprint server for biology·2026
Same author

Corrigendum to A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer.

The Journal of clinical investigation·2025
Same author

Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease.

Nucleic acids research·2025

Batten disease, a childhood neurodegenerative disorder, stems from mutations in the CLN3 gene. This review examines CLN3 protein structure and trafficking, suggesting its lysosomal localization is key to understanding the disease.

Area of Science:

  • Cell Biology
  • Neurogenetics
  • Biochemistry

Background:

  • Batten disease is an inherited neurodegenerative disorder affecting children, caused by mutations in the CLN3 gene.
  • The precise function of the CLN3 protein, a predicted membrane protein, remains largely unknown.
  • Understanding CLN3's cellular role is crucial for elucidating Batten disease pathology.

Purpose of the Study:

  • To critically review methodologies for studying CLN3 protein structure, trafficking, and localization.
  • To synthesize current knowledge regarding CLN3's cellular and subcellular context.
  • To provide insights into the potential impact of CLN3 dysfunction on lysosomal function.

Main Methods:

  • Review of existing literature on CLN3 protein studies.

Related Experiment Videos

  • Analysis of experimental approaches investigating CLN3's membrane topology, posttranslational modifications, and trafficking pathways.
  • Integration of data from various studies to infer CLN3's cellular residence.

    • Main Results:

    • CLN3 is likely localized to the lysosomal/endosomal membrane.
    • Conflicting models exist regarding CLN3's orientation within the lysosomal membrane.
    • CLN3 undergoes posttranslational modifications and is trafficked through the endoplasmic reticulum, Golgi, and potentially the plasma membrane.

    Conclusions:

    • CLN3's cellular and subcellular localization is primarily within the lysosomal/endosomal system.
    • Despite ongoing research, the exact function of CLN3 remains elusive.
    • Genetic defects in CLN3 are strongly implicated in affecting lysosomal function, contributing to Batten disease pathogenesis.